Ross D H, Cardenas H L
Neurochem Res. 1987 Jan;12(1):41-8. doi: 10.1007/BF00971362.
A high affinity Ca2+/Mg2+ ATPase has been identified and localized in synaptic membrane subfractions. This enzyme is stimulated by low concentrations of Ca2+ (less than or equal to microM) believed to approximate the range of Ca2+ in the synaptosomal cytosol (0.1 to 5.0 microM). The opiate agonist levorphanol, in a concentration-dependent fashion, inhibited Ca2+-stimulated ATP hydrolysis in lysed synaptic membranes. This inhibition was reversed by naloxone, while dextrorphan, the inactive opiate isomer, was without effect. Inhibition by levorphanol was most pronounced in a subfraction of synaptic membranes (SPM-1). The inhibition of Ca2+-stimulated ATP hydrolysis was characterized by a reduction in Vmax for Ca2+. Levorphanol pretreatment reduced the Hill coefficient (HN) of 1.5 to 0.7, suggesting cooperative interaction between the opiate receptor and the enzyme protein. Levorphanol, but not dextrorphan, also inhibited (28%) ATP-dependent Ca2+ uptake by synaptic membranes. Opiate ligand stereoisomers were tested for their effects on calmodulin stimulating of high affinity Ca2+/Mg2+ ATPase in synaptic membranes. Levorphanol (10 microM), but not the inactive stereoisomer (+)dextrorphan, significantly inhibited (35%) the calmodulin-activated Ca2+-dependent ATP hydrolysis activity in a preparation of lysed synaptic membranes. Both Ca2+-dependent and calmodulin-dependent stimulation of the enzyme in the presence of optimal concentrations of the other co-substrate were inhibited by levorphanol (35-40%) but not dextrorphan. Inhibition of ATP hydrolysis was characterized by a reduction in Vmax for both Ca2+ and calmodulin stimulation of the enzyme. Calmodulin stimulation of enzyme activity was most pronounced in SPM-1, the membrane fraction which also exhibits the maximal opiate inhibition (40%) of the Ca2+-ATPase.(ABSTRACT TRUNCATED AT 250 WORDS)
一种高亲和力的Ca2+/Mg2+ATP酶已在突触膜亚组分中被鉴定并定位。这种酶受到低浓度Ca2+(小于或等于微摩尔)的刺激,据信该浓度范围接近突触体胞质溶胶中的Ca2+浓度(0.1至5.0微摩尔)。阿片类激动剂左啡诺以浓度依赖的方式抑制裂解突触膜中Ca2+刺激的ATP水解。这种抑制作用可被纳洛酮逆转,而无活性的阿片类异构体右啡烷则无作用。左啡诺的抑制作用在突触膜的一个亚组分(SPM-1)中最为明显。Ca2+刺激的ATP水解的抑制表现为Ca2+的Vmax降低。左啡诺预处理将希尔系数(HN)从1.5降低到0.7,表明阿片受体与酶蛋白之间存在协同相互作用。左啡诺而非右啡烷也抑制(28%)突触膜对ATP依赖的Ca2+摄取。测试了阿片配体立体异构体对突触膜中钙调蛋白刺激高亲和力Ca2+/Mg2+ATP酶的影响。左啡诺(10微摩尔)而非无活性的立体异构体(+)右啡烷显著抑制(35%)裂解突触膜制剂中钙调蛋白激活的Ca2+依赖性ATP水解活性。在存在最佳浓度的其他共底物的情况下,左啡诺(35-40%)而非右啡烷抑制了该酶的Ca2+依赖性和钙调蛋白依赖性刺激。ATP水解的抑制表现为该酶对Ca2+和钙调蛋白刺激的Vmax降低。钙调蛋白对酶活性的刺激在SPM-1中最为明显,该膜组分对Ca2+-ATP酶也表现出最大的阿片抑制(40%)。(摘要截短于250字)